MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

The latest financial statement is for the quarter ending 2025-09-30.

Cash Flow Overview

Free Cash flow
-$52,568K

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Cash Flow
2025-09-30
2025-06-30
Net loss
-65,712 -108,494
Share-based compensation expense
7,495 13,427
Depreciation expense
356 565
Accretion of asset retirement obligation
23 -
Non-cash lease expense
621 972
Accretion of net investment discounts
3,291 9,537
Prepaid expenses and other current assets
2,177 5,109
Other non-current assets
397 1,096
Accounts payable
8,806 966
Accrued expenses and other current liabilities
3,881 2,611
Operating lease liabilities
-601 -1,092
Net cash used in operating activities
-50,996 -106,787
Purchases of short-term investments
248,824 204,932
Proceeds from maturities of short-term investments
195,919 288,453
Purchases of property and equipment
1,572 546
Advance payment received for sale of non-financial asset
5,158 -
Net cash provided by (used in) investing activities
-49,319 82,975
Proceeds from issuance of ordinary shares-At Market Common Stock Offering Program
57,058 -
Payments of offering costs
770 -
Proceeds from issuance of ordinary shares under employee share purchase plan
0 474
Proceeds from exercise of share options
377 1,008
Payment of taxes on restricted share units withheld for taxes
462 156
Net cash provided by financing activities
56,203 1,326
Net change in cash and cash equivalents
-44,112 -22,486
Cash and cash equivalents at beginning of period
169,510 -
Cash and cash equivalents at end of period
102,912 -
Unit: Thousand (K) dollars

Time Plot

Show the time plot by selecting a row from the table.

Structure Therapeutics Inc. (GPCR)

Structure Therapeutics Inc. (GPCR)